These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 30343885)
21. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180. Chau WF; Black AM; Clarke A; Durrant C; Gausemel I; Khan I; Mantzilas D; Oulie I; Rogstad A; Trigg W; Jones PA Nucl Med Biol; 2015 Sep; 42(9):711-9. PubMed ID: 26072270 [TBL] [Abstract][Full Text] [Related]
22. [¹⁸F]DPA-714 as a biomarker for positron emission tomography imaging of rheumatoid arthritis in an animal model. Pottier G; Bernards N; Dollé F; Boisgard R Arthritis Res Ther; 2014 Mar; 16(2):R69. PubMed ID: 24621017 [TBL] [Abstract][Full Text] [Related]
24. Quetiapine ameliorates collagen-induced arthritis in mice via the suppression of the AKT and ERK signaling pathways. Pan YJ; Wang WH; Huang TY; Weng WH; Fang CK; Chen YC; Hwang JJ Inflamm Res; 2018 Oct; 67(10):847-861. PubMed ID: 30109356 [TBL] [Abstract][Full Text] [Related]
25. Comparative Evaluation of Wang Z; Cai L; Xu T; Tang D; Liu L; Chen Y Contrast Media Mol Imaging; 2019; 2019():2353658. PubMed ID: 31015824 [TBL] [Abstract][Full Text] [Related]
26. Translocator protein (18 kDa), a potential molecular imaging biomarker for non-invasively distinguishing non-alcoholic fatty liver disease. Xie L; Yui J; Hatori A; Yamasaki T; Kumata K; Wakizaka H; Yoshida Y; Fujinaga M; Kawamura K; Zhang MR J Hepatol; 2012 Nov; 57(5):1076-82. PubMed ID: 22796156 [TBL] [Abstract][Full Text] [Related]
27. Imaging and Methotrexate Response Monitoring of Systemic Inflammation in Arthritic Rats Employing the Macrophage PET Tracer [ Chandrupatla DMSH; Jansen G; Mantel E; Low PS; Matsuyama T; Musters RP; Windhorst AD; Lammertsma AA; Molthoff CFM; van der Laken CJ Contrast Media Mol Imaging; 2018; 2018():8092781. PubMed ID: 29681783 [TBL] [Abstract][Full Text] [Related]
28. Efficient and automatic synthesis of TSPO PET ligand [ Zhu XX; He YL; Xie JK; Wang KX; Wang SC; Xie Q Appl Radiat Isot; 2022 Jun; 184():110213. PubMed ID: 35349890 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of Zhang Q; Lin X; Wang W; Zhang X; Lü M; Shao Z; Shi D; Zhang R; Shi H; Zhang Y; Pan J; Song G; Cheng K; Ge L; Wang L; Han J Mol Imaging Biol; 2023 Aug; 25(4):630-637. PubMed ID: 37020126 [TBL] [Abstract][Full Text] [Related]
30. The effect of PPAR-gamma agonist on (18)F-FDG uptake in tumor and macrophages and tumor cells. Kim SL; Kim EM; Cheong SJ; Lee CM; Kim DW; Jeong HJ; Lim ST; Sohn MH; Yim CY Nucl Med Biol; 2009 May; 36(4):427-33. PubMed ID: 19423011 [TBL] [Abstract][Full Text] [Related]
31. Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques. Ogawa M; Magata Y; Kato T; Hatano K; Ishino S; Mukai T; Shiomi M; Ito K; Saji H J Nucl Med; 2006 Nov; 47(11):1845-50. PubMed ID: 17079818 [TBL] [Abstract][Full Text] [Related]
32. Imaging disease activity of rheumatoid arthritis by macrophage targeting using second generation translocator protein positron emission tomography tracers. Bruijnen STG; Verweij NJF; Gent YYJ; Huisman MC; Windhorst AD; Kassiou M; van de Ven PM; Lammertsma AA; Hoekstra OS; Voskuyl AE; van der Laken CJ PLoS One; 2019; 14(9):e0222844. PubMed ID: 31553762 [TBL] [Abstract][Full Text] [Related]
33. Etanercept in combination with conventional disease-modifying antirheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis patients intolerant to methotrexate. Koyama Y; Shiraishi H; Ohta T; Uchino A Mod Rheumatol; 2012 Feb; 22(1):100-8. PubMed ID: 21706263 [TBL] [Abstract][Full Text] [Related]
35. Monitoring Therapy Response of Experimental Arthritis with Radiolabeled Tracers Targeting Fibroblasts, Macrophages, or Integrin αvβ3. Terry SY; Koenders MI; Franssen GM; Nayak TK; Freimoser-Grundschober A; Klein C; Oyen WJ; Boerman OC; Laverman P J Nucl Med; 2016 Mar; 57(3):467-72. PubMed ID: 26635344 [TBL] [Abstract][Full Text] [Related]
36. Reduction of methotrexate and glucocorticoids use after the introduction of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in daily practice based on the IORRA cohort. Shimizu Y; Tanaka E; Inoue E; Shidara K; Sugimoto N; Seto Y; Nakajima A; Momohara S; Taniguchi A; Yamanaka H Mod Rheumatol; 2018 May; 28(3):461-467. PubMed ID: 28880684 [TBL] [Abstract][Full Text] [Related]
37. (18)F-FDG and (18)F-NaF PET/CT demonstrate coupling of inflammation and accelerated bone turnover in rheumatoid arthritis. Watanabe T; Takase-Minegishi K; Ihata A; Kunishita Y; Kishimoto D; Kamiyama R; Hama M; Yoshimi R; Kirino Y; Asami Y; Suda A; Ohno S; Tateishi U; Ueda A; Takeno M; Ishigatsubo Y Mod Rheumatol; 2016; 26(2):180-7. PubMed ID: 26140472 [TBL] [Abstract][Full Text] [Related]
38. Assessment of collagen-induced arthritis using cyanine 5.5 conjugated with hydrophobically modified glycol chitosan nanoparticles: correlation with 18F-fluorodeoxyglucose positron emission tomography data. Cha JH; Lee SH; Lee SW; Park K; Moon DH; Kim K; Biswal S Korean J Radiol; 2012; 13(4):450-7. PubMed ID: 22778567 [TBL] [Abstract][Full Text] [Related]
39. Etanercept is effective as monotherapy or in combination with methotrexate in rheumatoid arthritis: subanalysis of an observational study. Gaubitz M; Göttl KH; Behmer O; Lippe R; Meng T; Löschmann PA Clin Rheumatol; 2017 Sep; 36(9):1989-1996. PubMed ID: 28756532 [TBL] [Abstract][Full Text] [Related]
40. Quantifying disease activity in rheumatoid arthritis with the TSPO PET ligand de Groot M; Patel N; Manavaki R; Janiczek RL; Bergstrom M; Östör A; Gerlag D; Roberts A; Graves MJ; Karkera Y; Fernando D; Mistry P; Walker A; Wisniacki N; Fryer TD; Jimenez-Royo P EJNMMI Res; 2019 Dec; 9(1):113. PubMed ID: 31858293 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]